Comparison of cilostazol and ticlopidine for one-month effectiveness and safety after elective coronary stenting

To compare the oral antiplatelets, phosphodiesterase III inhibitor cilostazol and the thienopyridine ticlopidine, for one-month effectiveness and safety as an adjunctive therapy after coronary stenting. Published studies retrieved through Medline and other databases from 1966-2002. Meta-analyses eva...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cardiovascular drugs and therapy 2004-05, Vol.18 (3), p.211-217
Hauptverfasser:	HASHIGUCHI, Masayuki, OHNO, Keiko, NAKAZAWA, Rieko, KISHINO, Satoshi, MOCHIZUKI, Mayumi, SHIGA, Tsuyoshi
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Aspirin - administration & dosage Aspirin - adverse effects Aspirin - therapeutic use Biological and medical sciences Cardiovascular system Coronary Restenosis - complications Coronary Stenosis - diagnosis Coronary Stenosis - therapy Coronary Vessels - surgery Data Collection - methods Data Interpretation, Statistical Death Documentation - classification Documentation - standards Drug Administration Schedule Drug Therapy, Combination Elective Surgical Procedures - adverse effects Elective Surgical Procedures - methods Evaluation Studies as Topic Humans Japan Medical Records - classification Medical Records - standards Medical sciences Myocardial Infarction - complications Odds Ratio Pharmacology. Drug treatments Stents - adverse effects Stents - utilization Tetrazoles - administration & dosage Tetrazoles - adverse effects Tetrazoles - therapeutic use Ticlopidine - administration & dosage Ticlopidine - adverse effects Ticlopidine - therapeutic use Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!